Treatment of endometriosis with the novel selective progesterone receptor modulator (SPRM) asoprisnil
article
OA: bronze
CC0
⤵ 32 in-corpus citations
AI-generated summary
This paper investigated the efficacy and safety of the novel selective progesterone receptor modulator (SPRM) asoprisnil for treating endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (32)
- Neuroimmunology of Endometriosis-Associated Pain and Its Psychological Aspects 2024
- Medical treatments of endometriosis: a review 2022
- Endometriosis diagnosis and medical treatment: Present and future 2021
- Selective Progesterone Receptor Modulators (SPRMs) and Androgen Receptor Modulators (SARMs) as Treatment for Benign Gynecologic Diseases 2021
- From pathogenesis to clinical practice: Emerging medical treatments for endometriosis 2018
- Medical treatment of endometriosis-related pain 2018
- Progesterone receptor modulators for endometriosis 2017
- Adenomyosis: a systematic review of medical treatment 2016
- Estrogen-progestins and progestins for the management of endometriosis 2016
- Hormonal therapy for endometriosis: from molecular research to bedside 2016
- An overview of early drug development for endometriosis 2015
- Endometriosis: alternative methods of medical treatment 2015
- Medical Treatments for Endometriosis-Associated Pelvic Pain 2014
- Medikamentöse Therapie der Endometriose 2014
- Hormontherapie bei gynäkologischen, nichtmalignen Erkrankungen 2013
- Medikamentöse Therapie der Endometriose 2013
- Progesterone receptor antagonists and progesterone receptor modulators for endometriosis 2012
- The immninent dawn of SPRMs in obstetrics and gynecology 2012
- New trends for the medical treatment of endometriosis 2012
- Tratamiento de la endometriosis con 5mg o 25mg diarios de mifepristona durante 6 meses. Ensayo clínico aleatorizado, doble ciego 2011
- Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety 2011
- Medikamentöse Therapie der chronischen Endometriose 2011
- Pharmacological treatment of endometriosis: update from recent clinical trials 2011
- Chronische Endometriose: medikamentöse Therapie 2010
- Medical treatment of endometriosis. 2009
- Endometriosis causing lower extremity deep vein thrombosis — case report and review of the literature 2009
- Treatment strategies for endometriosis 2008
- Investigational developments for the treatment of progesterone-dependent diseases 2008
- Progesterone receptor antagonists and selective progesterone receptor modulators: proven and potential clinical applications 2007
- The role of progestins in treating the pain of endometriosis 2006
- Role of nonhuman primate models in the discovery and clinical development of selective progesterone receptor modulators (SPRMs) 2006
- Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis 2005
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK